KM Research Hub
← 返回论文库
待处理 入排:待复核 图源:待检查 入排置信度 0.00

Durvalumab plus etoposide-carboplatin for advanced digestive neuroendocrine carcinoma: a phase III trial (JCOG2107E).

Yusuke Sano, Yuta Maruki, Chigusa Morizane, Shogo Nomura, Haruhiko Fukuda, Masafumi Ikeda, Masato Ozaka, Satoshi Kobayashi, Kazuyoshi Ohkawa, Nobumasa Mizuno, Hidetaka Tsumura, Nao Fujimori, Yoshito Komatsu, Noboru Takata, Ichiro Yasuda, Kohei Nakachi, Toru Otsuru, Takuya Honda, Takuji Okusaka, Makoto Ueno, Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group

Future Oncol 22(24) 2891-2897

PMID42911120
PMCIDPMC13757589
DOI10.1080/14796694.2026.2749305
发表日期2026-10-23
入排依据:未可靠识别 OS/PFS/DFS/EFS/RFS/TTP、Kaplan-Meier、HR 或其他 time-to-event 结局,需复核。
摘要

摘要

jRCT2031230456 (https://jrct.mhlw.go.jp/latest-detail/jRCT2031230456).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。